Recombinant human activated protein C for severe sepsis in neonates
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Activated Protein C for Severe Sepsis in Neonates." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438613/0/Metformin_for_endometrial_hyperplasia_New. Accessed 28 March 2024.
Recombinant human activated protein C for severe sepsis in neonates. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/0/Metformin_for_endometrial_hyperplasia_New. Accessed March 28, 2024.
Recombinant human activated protein C for severe sepsis in neonates. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/0/Metformin_for_endometrial_hyperplasia_New
Recombinant Human Activated Protein C for Severe Sepsis in Neonates [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/0/Metformin_for_endometrial_hyperplasia_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human activated protein C for severe sepsis in neonates
ID - 438613
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438613/0/Metformin_for_endometrial_hyperplasia_New
DB - Evidence Central
DP - Unbound Medicine
ER -